Medical membranes market is expected to reach USD 3.31 Billion by 2022, at a CAGR of 9.2%. This growth can be attributed to the increase in the number of ESRD patients worldwide. Moreover, the demand for artificial organs and organ transplant will also propel the growth of the medical membranes market in the healthcare sector. The rising incidences of patients undergoing dialysis is another factor driving the demand for medical membranes. Pall Corporation (US), Asahi Kasei (Japan), 3M (US), Koch Membrane Systems (US), Merck Millipore (US), and GE Healthcare (US) are major players operating in the medical membranes market.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=86
Nanofiltration is expected to be fastest-growing process technology during the forecast period.
Nanofiltration is a relatively new membrane filtration process used for the purpose of softening (polyvalent cation removal) and removal of disinfection byproducts. NF membranes reject multivalent ions with no selectivity towards monovalent ions, whereas RO membranes reject all solutes, including monovalent ions. This property enables NF membranes to operate at reduced operating pressures with increased flow rates as compared to RO. Thus, the use of nanofiltration process technology is gaining momentum in the market. In addition, research & development in solvent-stable membranes has expanded the applicability of nanofiltration in new areas, such as pharmaceuticals and fine chemicals, thereby driving the demand for nanofiltration process technology.
Pharmaceutical filtration is the largest application segment of the medical membranes market.
High incidences of renal disease, advancements in medical technology, expansion of the pharmaceutical and healthcare industries, and demand for high purity products and medicines are major factors driving the growth of the pharmaceutical application segment of the medical membranes market.
Europe led the medical membranes market in 2017.
The growth of the medical membranes market in Europe can be attributed to the increase in the number of ESRD patients, availability of improved diagnostic facilities, and high prevalence of chronic diseases, such as diabetes and hypertension.
On the Basis of Process Technology:
- Ultrafiltration
- Microfiltration
- Nanofiltration
- Others
On the Basis of Application:
- Pharmaceutical Filtration
- Hemodialysis
- Drug Delivery
- IV Infusion & Sterile Filtration
Speak to Analyst @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=86
